Targeted TFO delivery to hepatic stellate cells

Journal of Controlled Release

Volumn 155, Issue 2, 2011, Pages 326-330

  Yang, Ningning ^a   Singh, Saurabh ^a   Mahato, Ram I ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Bioconjugation; HPMA; Liver fibrosis; TFO

Indexed keywords

BIO-CONJUGATION; CARRIER MOLECULES; CELLULAR UPTAKE; COLLAGEN SYNTHESIS; DIRECT INTERACTIONS; GENOMIC DNA; HEPATIC STELLATE CELLS; HIGH MOLECULAR WEIGHT; HPMA; IMMUNOGENICITY; IN-VIVO; LIVER FIBROSIS; SERUM ALBUMIN; TARGET CELLS; TARGETED DELIVERY; TFO; TRIPLEX-FORMING OLIGONUCLEOTIDES;

BODY FLUIDS; OLIGONUCLEOTIDES;

GENES;

ANTISENSE OLIGONUCLEOTIDE; BETA ACTIN; BOVINE SERUM ALBUMIN; COLLAGEN TYPE 1; GENOMIC DNA; MANNOSE 6 PHOSPHATE; N (2 HYDROXYPROPYL)METHACRYLAMIDE; OLIGONUCLEOTIDE; PSORALEN; SMALL INTERFERING RNA; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRIPLEX FORMING OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA2 GLYCOPROTEIN; CHOLESTEROL; DRUG CARRIER; SERUM ALBUMIN;

ANTISENSE THERAPY; COLLAGEN SYNTHESIS; CONFERENCE PAPER; DISEASE SEVERITY; DRUG CONJUGATION; DRUG EFFICACY; DRUG UPTAKE; EPITHELIAL MESENCHYMAL TRANSITION; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; IMMUNOGENICITY; IMMUNOSTIMULATION; LIVER FIBROSIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RNA INTERFERENCE; STELLATE CELL; TRANSCRIPTION TERMINATION; CONJUGATION; DISULFIDE BOND; DNA STRUCTURE; DNA TRANSCRIPTION; DRUG DELIVERY SYSTEM; FIBROGENESIS; GENETIC TRANSCRIPTION; PARTICLE SIZE;

COLLAGEN; DNA; DRUG CARRIERS; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; MANNOSEPHOSPHATES; OLIGONUCLEOTIDES; SERUM ALBUMIN, BOVINE; TRANSCRIPTION, GENETIC;

EID: 80054116931     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.06.037     Document Type: Conference Paper

References (37)

1. S.L. Friedman Pathogenesis of liver fibrosis Annu. Rev. Pathol. Mech. Dis. 6 2011
2. Z. Ye, H.S.H. Houssein, and R.I. Mahato Bioconjugation of oligonucleotides for treating liver fibrosis Oligonucleotides 17 2007 349 404
3. S.L. Friedman Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver Physiol. Rev. 88 2008 125
4. M. Zeisberg, C. Yang, M. Martino, M.B. Duncan, F. Rieder, H. Tanjore, and R. Kalluri Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition J. Biol. Chem. 282 2007 23337 23347 (Pubitemid 47311952)
5. K. Cheng, and R.I. Mahato Gene modulation for treating liver fibrosis Crit. Rev. Ther. Drug Carrier Syst. 24 2007 93 146 (Pubitemid 47324848)
6. R. Fu, J. Wu, J. Ding, J. Sheng, L. Hong, Q. Sun, H. Fang, and D. Xiang Targeting transforming growth factor beta RII expression inhibits the activation of hepatic stellate cells and reduces collagen synthesis Exp. Biol. Med. 236 2011 291
7. J.P. Iredale Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ J. Clin. Invest. 117 2007 539
8. Z. Ye, H.S. Houssein, and R.I. Mahato Bioconjugation of oligonucleotides for treating liver fibrosis Oligonucleotides 17 2007 349 404
9. G. Son, I.N. Hines, J. Lindquist, L.W. Schrum, and R.A. Rippe Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis Hepatology 50 2009 1512 1523
10. S. Koilan, D. Hamilton, N. Baburyan, M.K. Padala, K.T. Weber, and R.V. Guntaka Prevention of liver fibrosis by triple helix-forming oligodeoxyribonucleotides targeted to the promoter region of type I collagen gene Oligonucleotides 20 2010 231 237
11. J. Joseph, J.C. Kandala, D. Veerapanane, K.T. Weber, and R.V. Guntaka Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts Nucleic Acids Res. 25 1997 2182 2188 (Pubitemid 27303454)
12. M. Nakanishi, K.T. Weber, and R.V. Guntaka Triple helix formation with the promoter of human alpha1(I) procollagen gene by an antiparallel triplex-forming oligodeoxyribonucleotide Nucleic Acids Res. 26 1998 5218 5222 (Pubitemid 28517582)
13. K.M. Vasquez, L. Narayanan, and P.M. Glazer Specific mutations induced by triplex-forming oligonucleotides in mice Science 290 2000 530 533
14. I. Radhakrishnan, and D.J. Patel DNA triplexes: solution structures, hydration sites, energetics, interactions, and function Biochemistry 33 1994 11405 11416 (Pubitemid 2147608)
15. D. Praseuth, A. Guieysse, and C. Hélne Triple helix formation and the antigene strategy for sequence-specific control of gene expression Biochim. Biophys. Acta Gene Struct. Expr. 1489 1999 181 206
16. J. Lindquist, W. Marzluff, and B. Stefanovic III Posttranscriptional regulation of type I collagen Am. J. Physiol. Gastrointest. Liver Physiol. 279 2000 G471
17. J. Joseph, J. Kandala, D. Veerapanane, K. Weber, and R. Guntaka Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha 1 (1) collagen gene promoter and inhibit transcription in cultured rat fibroblasts Nucleic Acids Res. 25 1997 182 188
18. Z. Ye, R.V. Guntaka, and R.I. Mahato Sequence-specific triple helix formation with genomic DNA Biochemistry 46 2007 11240 11252 (Pubitemid 47556753)
19. J.E. Wooldridge, Z. Ballas, A.M. Krieg, and G.J. Weiner Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma Blood 89 1997 2994
20. K. Cheng, Z. Ye, R.V. Guntaka, and R.I. Mahato Biodistribution and hepatic uptake of triplex-forming oligonucleotides against type alpha1(I) collagen gene promoter in normal and fibrotic rats Mol. Pharm. 2 2005 206 217 (Pubitemid 40917417)
21. R.Z. Yu, R.S. Geary, D.K. Monteith, J. Matson, L. Truong, J. Fitchett, and A.A. Levin Tissue disposition of 2 O (2 methoxy) ethyl modified antisense oligonucleotides in monkeys J. Pharm. Sci. 93 2004 48 59 (Pubitemid 38081813)
22. S. Agrawal, J. Temsamani, W. Galbraith, and J. Tang Pharmacokinetics of antisense oligonucleotides Clin. Pharmacokinet. 28 1995 7 16
23. S.L. Friedman Liver fibrosis - from bench to bedside J. Hepatol. 38 2003 38
24. R.I. Mahato, S. Takemura, K. Akamatsu, M. Nishikawa, Y. Takakura, and M. Hashida Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(-lysine) Biochem. Pharmacol. 53 1997 887 895 (Pubitemid 27145791)
25. S. Rajur, C. Roth, J. Morgan, and M. Yarmush Covalent protein-oligonucleotide conjugates for efficient delivery of antisense molecules Bioconjug. Chem. 8 1997 935 940 (Pubitemid 27526424)
26. K. Cheng, Z. Ye, R.V. Guntaka, and R.I. Mahato Enhanced hepatic uptake and bioactivity of type alpha1(I) collagen gene promoter-specific triplex-forming oligonucleotides after conjugation with cholesterol J. Pharmacol. Exp. Ther. 317 2006 797 805
27. L. Beljaars, G. Molema, B. Weert, H. Bonnema, P. Olinga, G.M. Groothuis, D.K. Meijer, and K. Poelstra Albumin modified with mannose 6-phosphate: a potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells Hepatology 29 1999 1486 1493 (Pubitemid 29211051)
28. Z. Ye, K. Cheng, R.V. Guntaka, and R.I. Mahato Targeted delivery of a triplex-forming oligonucleotide to hepatic stellate cells Biochemistry 44 2005 4466 4476 (Pubitemid 40403989)
29. L. Wang, J. Kristensen, and D.E. Ruffner Delivery of antisense oligonucleotides using HPMA polymer: synthesis of A thiol polymer and its conjugation to water-soluble molecules Bioconjug. Chem. 9 1998 749 757 (Pubitemid 28542243)
30. N. Yang, Z. Ye, F. Li, and R.I. Mahato HPMA polymer-based site-specific delivery of oligonucleotides to hepatic stellate cells Bioconjug. Chem. 20 2009 213 221
31. Z. Ye, K. Cheng, R.V. Guntaka, and R.I. Mahato Receptor-mediated hepatic uptake of M6P-BSA-conjugated triplex-forming oligonucleotides in rats Bioconjug. Chem. 17 2006 823 830 (Pubitemid 43794394)
32. R. Panakanti, A. Pratap, N. Yang, J.S. Jackson, and R.I. Mahato Triplex forming oligonucleotides against type alpha1(I) collagen attenuates liver fibrosis induced by bile duct ligation Biochem. Pharmacol. 80 2010 1718 1726
33. R. Bataller, and D.A. Brenner Liver fibrosis J. Clin. Invest. 115 2005 209 218 (Pubitemid 40385459)
34. A.M. Gressner, R. Weiskirchen, K. Breitkopf, and S. Dooley Roles of TGF-beta in hepatic fibrosis Front. Biosci. 7 2002 D793
35. M. Bauer, and D. Schuppan TGFbeta1 in liver fibrosis: time to change paradigms? FEBS Lett. 502 2001 1
36. K. Cheng, N. Yang, and R.I. Mahato TGF-1 gene silencing for treating liver fibrosis Mol. Pharm. 6 2009 772 779
37. N. Yang, and R.I. Mahato GFAP promoter-driven RNA interference on TGF-beta1 to treat liver fibrosis Pharm. Res. 28 2011 752 761